Sign In
Buy SRTS
$2.84
+0 (+0%)
At Close: Jun 03, 2026
Sensus Healthcare, Inc. Investors: Company Investigated by the Portnoy Law Firm
03:43pm, Thursday, 28'th Aug 2025
Investors can contact the law firm at no cost to learn more about recovering their losses
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
10:00am, Wednesday, 27'th Aug 2025
NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ: SRTS). Such investors are advis
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
11:45am, Monday, 25'th Aug 2025
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. (“Sensus” or the “Company”) (NASDAQ: SRTS). Such invest
SRTS Investors Have Opportunity to Join Sensus Healthcare, Inc. Fraud Investigation with the Schall Law Firm
05:34pm, Sunday, 24'th Aug 2025
LOS ANGELES--(BUSINESS WIRE)---- $SRTS--SRTS Investors Have Opportunity to Join Sensus Healthcare, Inc. Fraud Investigation with the Schall Law Firm.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
10:00am, Friday, 22'nd Aug 2025
NEW YORK , Aug. 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ: SRTS). Such investors are advis
Sensus Healthcare, Inc. Investors: Company Investigated by the Portnoy Law Firm
05:40pm, Thursday, 21'st Aug 2025
Investors can contact the law firm at no cost to learn more about recovering their losses
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
01:24pm, Thursday, 21'st Aug 2025
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. (“Sensus” or the “Company”) (NASDAQ: SRTS). Such invest
Is Sensus Healthcare (SRTS) a Buy as Wall Street Analysts Look Optimistic?
10:30am, Thursday, 21'st Aug 2025
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Sensus Healthcare, Inc. (SRTS) Q2 2025 Earnings Call Transcript
02:43pm, Friday, 08'th Aug 2025
Sensus Healthcare, Inc. (NASDAQ:SRTS ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Javier Rampolla - Chief Financial Officer Joseph C. Sardano - Co-Founder, Chairma
Sensus Healthcare, Inc. (SRTS) Reports Q2 Loss, Misses Revenue Estimates
07:35pm, Thursday, 07'th Aug 2025
Sensus Healthcare, Inc. (SRTS) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of $0.01. This compares to earnings of $0.1 per share a year ago.
Sensus (SRTS) Q2 Revenue Falls 21%
04:55pm, Thursday, 07'th Aug 2025
Sensus (SRTS) Q2 Revenue Falls 21%
Sensus Healthcare, Inc. (SRTS) Stock Drops Despite Market Gains: Important Facts to Note
07:16pm, Friday, 25'th Jul 2025
In the most recent trading session, Sensus Healthcare, Inc. (SRTS) closed at $5.51, indicating a -2.48% shift from the previous trading day.
Sensus Healthcare to Report Second Quarter 2025 Financial Results and Hold Business Update Conference Call on August 7
04:15pm, Thursday, 24'th Jul 2025
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for
Why Sensus Healthcare, Inc. (SRTS) Outpaced the Stock Market Today
07:16pm, Thursday, 17'th Jul 2025
Sensus Healthcare, Inc. (SRTS) reached $4.44 at the closing of the latest trading day, reflecting a +2.54% change compared to its last close.
Sensus Healthcare, Inc. (SRTS) Declines More Than Market: Some Information for Investors
07:16pm, Tuesday, 01'st Jul 2025
Sensus Healthcare, Inc. (SRTS) closed at $4.64 in the latest trading session, marking a -2.11% move from the prior day.
